Biotech Values

[floblu14]

MNTA European/U.S. Patent Applications Update for RMF - Plus MNTA Overview of their Patent Estate -

1.HIGH MANNOSE GLYCANS 2013-09-05

Abstract:
Methods and compositions related to high mannose glycans are described.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130905&CC=US&NR=2013231255A1&KC=A1

2.Amino Acid Copolymer Assay 2013-08-15

Abstract:
The present disclosure relates to polarized type 2 T helper (Th2) cells and methods for using such cells in the assessment of antigenic compositions.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130815&CC=US&NR=2013210054A1&KC=A1

3.CHARACTERIZATION OF N-GLYCANS USING EXOGLYCOSIDASES
2013-07-18

Abstract:
The present disclosure provides methods for analyzing structure and/or composition of N-glycans. Such methods often involve digestion of N-glycans with multiple exoglycosidases. In some embodiments, N-glycans are digested with multiple exoglycosidases simultaneously. In some embodiments, N-glycans are digested with multiple exoglycosidases sequentially. In some embodiments, methods in accordance with the present disclosure involve comparison of cleavage products of N-glycans that have been digested with multiple exoglycosidases simultaneously to N-glycans that have been digested with multiple exoglycosidases sequentially.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130718&CC=US&NR=2013184180A1&KC=A1

4.METHODS AND COMPOSITIONS FOR PROMOTING HAIR GROWTH -
*****3rd UPDATE 2013-07-18

Abstract:
Methods and compositions related to promoting hair growth are described. [No updated description inorder to differentiate.]

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130718&CC=US&NR=2013183254A1&KC=A1

5.NUCLEOTIDE CLONING METHODS 2013-07-18

Abstract:
Methods of cloning insert sequences into cloning vectors with high efficiency and in the correct orientation are described. In one aspect, the invention features a method of producing a plasmid comprising an insert fragment and a vector fragment in a predetermined orientation. In some embodiments, the method includes cleaving a first nucleotide sequence at a plurality of sites with a first restriction enzyme to generate a first population of nucleotide fragments, the first population of nucleotide fragments comprising insert fragments and non-insert fragments, the insert fragments comprising a non-palindromic overhang at a 5' end, at a 3' end, or at both

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=2&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130718&CC=WO&NR=2013106616A1&KC=A1

6.EVALUATING HEPARIN PREPARATIONS FOR PHARMACEUTICAL USE
2013-07-11

Abstract:
The disclosure features methods of analyzing preparations of heparin, and materials derived from heparin using strong anion exchange high performance liquid chromatography (SAX-HPLC).

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=3&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130711&CC=US&NR=2013177992A1&KC=A1

7.TISSUE TARGETING 2013-02-20

Abstract:
Methods and compositions related to targeting agents to tumor tissue are described.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130220&CC=EP&NR=2558506A2&KC=A2

8.POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT AND PREVENTION OF DISORDERS ASSOCIATED WITH PROGENITOR CELL MOBILIZATION 2013-02-20

Abstract:
Polysaccharide preparations lacking substantial anticoagulant activity are provided herein. Methods of making and using such preparations are provided.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130220&CC=EP&NR=2558124A1&KC=A1

9.STRUCTURE ASSESSMENT OF HETEROGENEOUS POLYPEPTIDE MIXTURE
2013-02-14

Abstract:
Methods of analyzing glatiramer acetate (GA) to assess secondary structure, for example, alpha helical content and/or random coil content thereof are provided as are methods for preparing a composition comprising GA and methods for identifying a copolymer as GA.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=2&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130214&CC=US&NR=2013041176A1&KC=A1

10.SELECTION AND USE OF HOST CELLS FOR PRODUCTION OF GLYCOPROTEINS 2013-02-13

Abstract:
A method of making a glycoprotein having a selected glycostructure.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=3&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130213&CC=EP&NR=2555801A1&KC=A1


PATENTS

We license or own a patent portfolio of over 70 patent families, each of which includes United States patent applications and/or issued patents as well as foreign counterparts to certain United States patents and patent applications. Our patent portfolio includes issued or pending claims covering:

*Methods and technologies for characterizing polysaccharides and other heterogeneous mixtures

*The composition of matter and use of certain heparinases, heparinase variants and other enzymes

*Methods and technologies for synthesis of polysaccharides

*The composition of matter and use of certain novel low molecular weight heparin products, including M402

*Methods to identify, analyze and characterize glycoproteins

*Methods of manufacture of certain polysaccharide, polypeptide and complex protein or biologic products

http://www.momentapharma.com/technology/patents.php